Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong - the HONG KONG PECT Registry
Chinese University of Hong Kong
1,000 participants
Jun 1, 2022
OBSERVATIONAL
Conditions
Summary
This retrospective cohort study (Hong Kong PECT Registry) compares treatment outcomes between different percutaneous catheter-based therapies in patients with acute pulmonary embolism (PE). PE is a critical condition with potential for rapid deterioration and mortality before treatment. While availability of catheter-based therapy contributed to the declining mortality rates of PE, selecting the appropriate intervention remains key. There are primarily two modes of therapies available: Catheter-directed thrombolysis and Aspiration thrombectomy (e.g., Penumbra, Flowtriever, AlphaVac) Given limited direct comparisons between these methods, the study will evaluate their efficacy, safety, and clinical outcomes of these treatment strategies in acute PE patients.
Eligibility
Inclusion Criteria2
- Patients who is admitted with a diagnosis of acute pulmonary embolism
- Patient who receives any types of catheter-based therapy for acute pulmonary embolism.
Exclusion Criteria1
- nil. This is a all-comer registry.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
catheter-based therapy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07029841